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ABSTRACT
Diabetes mellitus (DM) is a serious health problem in Indonesia. Type 2 diabetes 
is a metabolic disease which primarily caused by obesity-linked insulin resistance. 
There is a link between insulin resistance and bacterial populations in the gut. 
Therefore, the aims of this study was to analyze composition of bacteria belong to 
the phylum Firmicutes and Bacteroidetes in women with type 2 diabetes and non-
diabetic persons as control. The study included five female adults type 2 diabetes 
patients and five healthy controls. The bacteria composition was analyzed for 
abundance by denaturing gradient gel electrophoresis (DGGE). Metagenomic 
analysis based on 16S rRNA gene was represented by 12 DGGE bands. The twelve 
respective bands showed the similarity ranging from 77 up to 98%. Diversity of 
microbial composition in women type 2 diabetes was represented by five DGGE 
bands are Bacteroides fragilis, Bacteroides vulgatus, uncultured Bacteroides 
sp. clone Lb4eF4, uncultured bacterium clone 16sms90-5g05, and uncultured 
bacterium clone Malaga 1F14. Four DGGE bands in women healthy controls are 
closely related to uncultured bacterium isolate DGGE gel band Eub42, uncultured 
bacterium isolate DGGE gel band K115, uncultured bacterium clone HFV04255, 
and Enterococcus sp. the finding shows bacterial species belong to the phylum 
Bacteroidetes was mostly found in women diabetic group, while those belong to the 
phylum Firmicutes was mostly found in healthy controls.
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1. Introduction
Diabetes mellitus (DM) is a serious world health 
problem. According to the data of International 
Diabetes Federation (2015), a number of DM cases 
in worldwide exceeds 415 million patients. This 
number is expected to increase 642 million patients 
in 2040. Indonesia ranks 7th out of 10 countries 
with most DM contributors in the world. Data 
of KEMENKES (2013), the total of DM patients in 
Indonesia achieves 12 million people in 2013 and it 
will mount gradually. This disease actually is caused 
by an increase of glucose in blood that is impacted 
by an impaired insulin secretion. Furthermore, 
more than 90% of diabetes cases are DM type 2 (IDF 
2015). Diabetes in this type is more in consequence 
of in effective insulin usage by the human body that 
is characterized by obesity (Harstra et al. 2015). 
Kootte et al. (2012) report that a composition change 
of microbiota diversity in the gut will lead to an 
unbalanced microbiota that triggers appearing some 
diseases, one of them is diabetes mellitus. 
One of the metabolism changes is a Short Chain 
Fatty Acid (SCFA) fermentation such as butyrate, 
acetate, succinate, and propionate. The SCFA is able 
to be used for different tracks based on numbers 
and types of microbiota that are available in the 
intestines. A ratio between Bacteroidetes and 
Firmicutes will liven up in patients with DM type 2 
which is positively correlated to decrease tolerance 
on glucose (Larsen et al. 2010). Certain bacteria 
species from phylum Firmicutes are able to produce 
butyrate for preserving intestinal epithelium that 
inflammation in the gut is avoided. The abundance 
of Bacteroidetes is highly related to decreasing body 
weight. The Firmicutes will drop into a hypocaloric 
condition that the Bacteroidetes is able to proliferate 
in the intestine. A high abundance of Bacteroidetes 
can convert lactate to become acetate, succinate, 
and propionate that are able to harm intestinal 
epithelium and trigger inflammation and resistance 
towards glucose where impacting to occur diabetes 
mellitus disease (Remely et al. 2013).
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Several pieces research have been conducted to 
analyze the diversity of intestinal microbiota that 
is contributed to the DM disease. However, a faced 
obstacle recently is an absence of a clear consensus 
relating to microbiota data. Microbiota growth in the 
intestine is highly affected by several factors namely 
genetic, diet, food type, and geographic (Kinross 
et al. 2011) where every individual has a different 
microbiota diversity. Based on a research that has 
been carried out by Wu et al. (2010) for six adult 
women of DM type 2 patients in China infer that the 
abundance of Bacteroidetes in DM patients (53.6%) is 
higher than healthy people (11.8%). Another research 
that has been conducted by Harstra et al. (2015) for 
women with DM type 2 in Sweden found that phylum 
Bacteroidetes decrease in the DM patients and the 
phylum Firmicutes increases. Metagenomic analysis 
of intestinal microbiota in women patients of DM 
type 2 is never been reported in Indonesia previously. 
Therefore, a study about the microbiota diversity is 
necessarily important to be carried out as an effort to 
analyze a mark of microbiota that is associated with 
DM type 2 disease events. Hence, this research was 
aimed to analyze composition of bacteria belong to the 
phylum Firmicutes and Bacteroidetes in women with 
type 2 diabetes and non-diabetic persons as control. 
2. Materials and Methods
2.1. Sample Collection
Samples of feces were taken from a population 
that was consisted of 30 patients and 30 non-patients 
as respondents. Those respondents were delivered 
questionnaires to compile information related to 
several characteristics such as women with ages in 
range of 25 to 67 years old, willing to sign an informed 
consent letter, willing not to take antibiotic drugs for 
6 months (Goossens et al. 2005) and no being suffered 
from diarrhea to avoid pathogenic bacteria in their 
feces. Patients of DM type 2 is characterized by an in 
the course of blood glucose rate in blood capillaries 
≥200 mg/dl with body mass index (BMI) which is 
based on WHO (2018) namely less (≤18.5 kg/m2), 
normal (18.5-24.9 kg/m2), pre-obesity (≥25 kg/m2), 
and obesity (≥30 kg/m2). Determination of samples 
was based on the criteria above resulting five-woman 
respondents of patients with DM type 2 and five-
woman respondents of non-patients. Feces of those 
respondents were stored in closed sterile containers 
under 4oC condition and then they were conveyed to 
a laboratory for analyzing. 
2.2. DNA Extraction and Quantification
An extraction of DNA from samples of feces was 
carried out by using a kit ZymobiomicsTM DNA Miniprep 
Kit (USA). Concentration and DNA purification were 
then analyzed by using a NanoDrop 2000 (Thermo 
Scientific, Wilmington, DE, USA).
2.3. PCR Amplification of 16S rRNA Gene
Amplification step was executed by using 
a Polymerase Chain Reaction (PCR) method 
with T1-thermocycler (Biometra, Goettingen 
Germany). The used primers were P338F-GC 
(5'-CGCCCGCCGCGCGCGGCGGGCGGGGCGGGGGCAC 
GGGGGGACTCCTACGGGAGGCAGCAG-3’) and P518R 
(5’-ATTACCGCGGCTGCTGG-3’) (Overeas et al. 1997). 
Amplification was taken by utilizing a GoTaq Green 
Mastermix 2x (Promega, Madison, USA), with a 
composition of PCR as follows 12.5 µl of Gotaq Green 
Promega, two primers (P338F and P518R were 2.5 µl, 
DNA template 0.5 µl (21 ng/µl), respectively) and an 
additional nuclease-free water until the final volume 
exceeded 30 µl. The PCR was conditioned for several 
treatments such as pre-denaturation under 94oC for 
5 minutes, denaturation under 94oC for 30 seconds, 
annealing under 55oC for 30 seconds, elongation under 
72oC for 30 seconds as many as 30 cycles. Results of the 
PCR then were electrophoresed in 1.5% agarose gel and 
furthermore were documented in a G:BOX (Syngenee 
Frederick, MD, USA).
2.4. DGGE Analysis of the 16S rRNA Gene  
The resulted PCR of gene 16S rRNA was migrated 
into an 8% (w/v) polyacrylamide gel that was created 
from acrylamide-bisacrylamide [37.5:1] in 1x Tris-
asetate-EDTA (TAE). The gradient of denaturant was 
set between 35 to 65% and the denaturant becoming 
100% was formulated by adding 7M of urea and 40% 
(v/v) of formamide. The electrophoresis process was 
conditioned under temperature 600C and voltages 60 
Volt as long as15 hours by using a D Code Universal 
Mutation Detection System (Bio-Rad, Hercules, CA, USA).
Visualization of the resulted process was documented 
by using a G:BOX (Syngenee, Frederick, MD, USA). The 
resulted photo of gel doc was then analyzed by a Labimage 
ID software. The separated DNA band was cut by using 
a sterile scalpel knife and put in a tube containing a 
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100 µl ddH2O and then eluted. The product of DGGE 
furthermore was amplified using a primer gene 16S 
rRNA without using a GC-clamp (Muyzer et al. 1993).
 
2.5. 16S rRNA Gene Sequencing, Bioinformatics 
Analysis, and Phylogeneetic Tree Construction
The cut gel containing eluted DNA band was then 
amplified again with the DNA which was functioned 
as a template. Amount of 50 ng of DNA was amplified 
by using a specific primer P338F/P518R without GC 
clamps. The successful amplified DNAs were then sent 
to a Sequencing Service Company (Macrogene Korea) for 
sequencing process. The sequenced DNAs were analyzed 
using a ChromasPro software (Technelysium, AU) for 
assembling process and trimming. Homology analysis 
was administered by comparing sequenced DGGE bands 
with a gene bank database through a software of Basic 
Local Alignment Search Tool Nucleotide (BLAST-N) (www.
blast.ncbi.nlm.nih.gov). The gained homolog sequences 
were further aligned by using a MEGA 6.0 software 
(Tamura et al. 2013) with a Neighbor-Joining Method. 
A clustering analysis was taken based on the profile 
of DGGE that had been interpreted by using Labimage 
ID and PAST 3 software. 
2.6. Ethical Considerations
The research protocol was approved by the Ethics 
Committee of the Faculty of Medicine, the University 
of Indonesia (No:17-08-0788).
3. Results
3.1. Respondent Characteristics
Respondents consisted of two groups namely 
DM type 2 patients and non-patients as the control. 
The population of this research was students and 
housewives who are living in around Babakan Raya, 
Dramaga, Bogor, West Java. Those respondents were 
categorized according to Body Mass Index (BMI) which 
patients and non-patients, pre-obesity, and obesity, 
were 7 persons, 1 person, and 2 persons, respectively 
(Table 1). Eating habit of patients (P1-P5) in consuming 
foodsis more similar with less time intensity per day 
than non-patients (C1-C5). The eating habits of control 
in consuming foods is more varied with more time 
intensity per day. 
3.2. Analysis of Gene 16S rRNA in Feces Samples 
Amplification of gene 16S rRNA in feces sample 
used a universal primer of bacteria namely P338F/
P518R that specifically amplified V3 region in 16S rRNA. 
There were 10 samples that had been amplified and 
generatea single band. The product of PCR gene 16S 
rRNA of bacteria in feces sample was analyzed by using 
a nested PCR technique. This technique applies two 
times of PCR. The first and second steps of PCR exhibit 
a proper amplicon size with the allowed fragment size 
namely ±200 pb (Figure 1).
3.3. Metagenomic Analysis of Bacteria 
Community
This research used a non-culture approach 
(metagenomic) with DGGE technique. Based on the 
band distribution pattern of polyacrylamide gel, the 
community of feces bacteria of control is in range of 
15 bands at sample K1 to 22 bands at sample K3. This 
result is more uniform than the patients of DM type 2 
that is in range of 14 bands at sample P5 to 18 bands at 
sample P3 (Figure 2). Direct observation and position 
consideration of resulted DGGE bands point out that 
there are three DGGE bands which always appear for 
all samples (band 4, 9, 10), and five bands are only 
found in samples of patients (band 2, 5, 7, 8, 12), and 
four bands which are only discovered in samples of 
control (band 1, 3, 6, 11). Those twelve separated bands 
are successfully isolated through gel cut for further 
sequencing analysis of their DNA.
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Table1. Characteristics of patients and non-patients of DM type 2
Abbreviation: p = patient, k = control (non-patient), BMI = body mass index, RBG = random blood glucose
Sample
P1
P2
P3
P4
P5
K1
K2
K3
K4
K5
53
67
62
57
47
25
25
26
47
30
18.8
28.6
30.0
31.0
22.1
20.3
23.6
23.1
22.1
22.4
407
243
263
210
400
  77
  90
  85
101
  88
Information
Sick
Sick
Sick
Sick
Sick
Healthy
Healthy
Healthy
Healthy
Healthy
Eating habits
  Age
(year)
   BMI
(kg/m2)
  RBG
(mg/dl)
Consuming
staple foods 
(time/day)
2
1
1
2
1
3
3
3
3
3
Consuming 
vegetable 
(time/day)
1 
2 
1 
1 
1 
3 
3 
3 
2 
3 
Consuming 
     fruits 
(time/day)
1 
1 
1 
1 
1 
2 
3 
3 
2 
2 
Consuming
     snack
(yes or not)
Not
Not
Not
Not
Not
Yes
Yes
Yes
Yes
Yes
Consuming 
  fast food
(yes or not)
Not
Not
Not
Not
Not
Yes
Yes
Not
Yes
Not
A diversity analysis of Shannon-Wienner Index (H’) 
was used to estimate bacterial diversity in each sample 
in both DM type 2 patients and normal respondents. The 
estimation results signify that the Shannon-Wienner 
Index (H’) commonly community of bacterial feces of 
control based on gene 16S rRNA is in range of 2,624-
2,997, while DM type 2 patients are in range of 2,476-
2,829. Furthermore, the evenness index (e’) is in range 
of 0.8422-0.9604 that is categorized into high category. 
A high category of this index is where e’>0.6 (Figure 3).
The advanced analysis is a sequential analysis where 
used a Chromas Pro software. Alignment result of 
nucleotide shows that nine bands of DGGE are majority 
identified as an uncultured bacterium, however, three 
bands of the identified DGGE are Bacteroides vulgatus, 
Bacteroides fragilis, and Enterococcus sp. (Table 2). In 
10,000 bp
  1,000 bp
     250 bp
     200 bp
Figure 1. Visualization of resulted DNA amplification of gene 16S RNA in agarose 1.5%, M=a mark of DNA molecule; P1, P2, 
P3, P4, P5: feces samples of DM type 2 patients; K1, K2, K3, K4, K5: feces sample of healty respondent as control
K1 K1 K1 K1 K1
K1 K1 K1 K1 K1
3
4
2
5
7
12
8
1
6
9
11
10
Figure 2. Ilustration of DGGE band of gene 16S rRNA using a labimage 1D software. K1, K2, K3, K4, K5: feces sample of control; P1, 
P2, P3, P4, P5: feces sample of patients with DM type2. The sequential numbers exhibit bands that were cut for re-PCR
0 K1 K2 K3 K4 K5 P1 P2 P3 P4 P5
In
de
x 
H
'/e
'
0.5
1
1.5
2
2.5
3
3.5
Samples
Indeks shannon-wienner
Indeks kemerataan
Figure 3. Diversity index of shannon-wiennerand everness 
index of bacterial community based on gene 16S 
rRNA in 10 feces samples. K1, K2, K3, K4, K5: 
feces samples of control; P1, P2, P3, P4, P5: feces 
samples of DM type 2 patients
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their phylum. The phylogenetic tree is constructed by a 
neighbor-joining tree model namely Kimura 2-parameter 
model with bootstrap 2000x (Figure 4).
commonly, a percentage of sequence similarity of the 
resulted DGGE with database genebank target is about 
77-98%. Based on the phylogenetic analysis of gene 16S 
rRNA, grouping types of bacteria arein according with 
Table 2. Homology analysis of bacteria metagenome based on 16S rRNA sequence
Band
1
2
3
4
5
6
7
8
9
10
11
12
Description
Uncultured bacterium isolate 
DGGE gel band Eub_42
Bacteroides fragilis strain 
DBT194
Uncultured bacterium isolate 
DGGE gel band K1-15
Uncultured Bacteroidetes 
bacterium clone SS37
Bacteroides vulgatus strain
DNF00399
Uncultured bacterium clone
HFV04_255
Uncultured Bacteroides sp. clone
Grap1_Lb4e_F4
Uncultured bacterium clone
16sms90-5g05
Uncultured bacterium clone
nbw79c03c1
Uncultured bacterium clone 
LN07
Enterococcus sp. strain C12
Uncultured bacterium clone
G02_2_2a5_Malaga_1F_14
Query cover
(%)
No. access
GQ411146
MH482986
KF880980
HM442603
KU726654
GU105100
KP716770
JF259225
GQ064768
AY980738
MH754157
FJ345877
3e-69
3e-79
1e-81
6e-86
6e-91
1e-22
4e-73
4e-72
7e-10
1e-32
1e-93
7e-30
93
95
99
97
99
89
93
97
76
81
99
87
  85
100
100
100
100
  54
100
100
100
100
100
  77
Phylum
Firmicutes
Bacteroidetes
Firmicutes
Bacteroidetes
Bacteroidetes
Firmicutes
Bacteroidetes
Firmicutes
Firmicutes
Bacteroidetes
Firmicutes
Bacteroidetes
Identity
(%)
E-value
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Figure 4. Phylogenetic tree (neighbor joining tree) of 16S rRNA using Jukes Cantor model with boostrap 2000x. Sequential 
numbers indicate sequented bands
Pita DGGE DM 2
Pita DGGE DM 12
Pita DGGE DM 5
63
43
64
24
23
32
75
35 84
12
35
81
11
35
94
55
28
0.1
26
39
Pita DGGE DM 7
Pita DGGE DM 8
Bacteroidetes
Firmicutes
Pita DGGE DM+S 10
Pita DGGE DM+S 4
Pita DGGE DM+S 9
Pita DGGE Sehat 3
Pita DGGE Sehat 6
Pita DGGE Sehat 11
Pita DGGE Sehat 1
MH482986 Bacteroides fragilis strain DBT194
FJ345877 Uncultured bacterium clone G02 2 2a5 
KU726654 Bacteroides vulgatus strain DNF00399
KP716770 Uncultured Bacteroides sp. clone Grap1 Lb4e F4
HM442603 Uncultured Bacteroidetes bacterium clone SS37
AY980738 Uncultured bacterium clone LN07
KF880980 Uncultured bacterium isolate DGGE gel band K1-15
GU105100 Uncultured bacterium clone HFV04 255
MH748633 Enterococcus durans strains MYSN109
GQ411146 Uncultured bacterium isolate DGGE Eub 42
JF259225 Uncultured bacterium clone 16sms90-5g05
GQ064768 Uncultured bacterium clone nbw79c03c1
NR 102985 Pyrolobus fumarii strain 1A
4. Discussion
Respondents in this research are women. Yulianti et al. 
(2014) report that prevalence of women who are suffered 
from diabetes mellitus is higher than men due to their 
activities is less to produce energy. The gene 16S rRNA of 
feces samples were analyzed by using a universal primer 
namely P338F/P518R (Overeas et al. 1997). This primer 
is designed to amplify all regions of V3 in 16S rRNA. The 
Gene 16S rRNA has nine hypervariable regions (V1-V9). 
These regions are very effective for designing a mark 
in identifying bacteria. In geneeral, regions V2 and V3 
are very appropriate in distinguishing a various type of 
bacteria in geneus level. The region V2 has a long alkalinity 
of 106 nucleotides, while V3 only has 65 nucleotides 
(Chakravorty et al. 2007). In this research, the region 
V3 was used due to it is able to provide phylogenetic 
information adequately about bacteria that are presented 
in a sample (Huse et al. 2008).
Based on a melting pattern that is caused by denaturant 
gradient in a polyacrylamide gel, the DNA fragment with 
different sequence will migrate with a different position 
that yield a band pattern which represent a different 
taxon. According to Crosby and Criddle (2003), DGGE 
is able to distinguish a sequence of species based on a 
differentiation of melting temperature (Tm) in a DNA. 
Melting temperature in a DNA sequence is affected by 
G-C alkaline compound in DNA (Muyzer et al. 1993). 
Metagenomic approach with DGGE has several advantages 
such as more efficient, quick, and a good result to compare 
diversity structure of a total community of microbiota 
(Fuji et al. 2006). Therefore, the DGGE technique is able 
to differentiate species based on GC composition of 
analyzed sequence in the analysis (Overeas et al. 1997).
In this research, not all bands were cut and sequenced. 
Band selection in all samples were aimed to seek a more 
dominant bacteria. While the band was only found in the 
DM patients or only in the control (non-patients) that 
can be used for a mark of intestinal microbiota that are 
associated with metabolism process of health people 
and DM type 2 patients. 
Results of analyzing Shannon-Wienner (H’) indicates 
that feces samples of control have more diversity and 
varied of Operational Taxonomic Unit (OTU) than the 
diversity of OUT in feces samples of DM type 2 patients. 
However, overall diversity category of those sample feces 
was appertained into medium with Shannon index among 
1>H>3.5. The similar result also has been reported by Wu 
et al. (2010) that there is no difference of Shannon-Wienner 
Index (H’) for feces bacteria community of control and 
DM type 2 patients within averaged of 0.94 which is 
included low category. The current research also points 
out that the evenness index (e’) of all feces samples for 
both control and patients is similar each other. 
Furthermore, band 1 (Uncultured Roseburia sp. clone 
QY27 is found in control and band 5 (Bacteroides vulgatus 
strain NMBE-5) was in DM type 2 patients are unique 
bands that have the highest abundance. These both 
bands are able to be presumed as marks for intestinal 
microbiota that are associated with metabolism process 
in both control and patients of DM type 2. Roseburia sp. 
is a member of phylum Firmicutes, while B. vulgatus is a 
member of phylum Bacteroidetes. Both phyla are bacterial 
phylum that present in gut dominantly (Gill et al. 2006). 
In general, sequenced bands for DM type 2 patients come 
from phylum Bacteoridetes, and conversely, phylum 
Firmicutes is commonly for control or healthy people. 
Larsen et al. (2010) have reported that the abundance 
Firmicutes is higher in healthy people than DM type 2 
patients. 
Harstra et al. (2015) reported that Roseburia sp. is a type 
of bacteria that produce butyrate for preserving intestinal 
epithelium toward inflammation. The inflammation is able 
to disturb insulin signaling, that insulin is able to work 
maximally in controlling blood glucose for keeping normal. 
In another hand, B. vulgatus is able to change lactate in 
guts to become succinate, acetate, and propionate that 
can cause a disruption of intestinal permeability (Mejia-
Leon and Calderon de la Barca 2015). This matter causes 
alipopolysaccharide (LPS) composing cell wall of gram-
negative bacteria that should be in alimentary canals 
entering blood circulation and triggering an inflammation. 
This condition is able to activate Toll-like receptor (TLR) 
where the inflammation mediator like inhibitor NF-KB 
kinase (IKK) in metabolism track will inhibit signaling of 
insulin. It is impacted to targeted cells of insulin will be 
failed or unable to respond to insulin normally that the 
glucose rate is high in the blood (Wellen dan Hotamisligil 
2005). 
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